EC approves extension of indication for Janssen-Cilag's Darzalex
Janssen-Cilag is a Johnson & Johnson (J&J) company.
The approval allows for the use of daratumumab SC in conjunction with bortezomib, lenalidomide and dexamethasone (daratumumab-VRd).
The therapy currently holds nine indications approved for multiple myeloma (MM) with five for frontline treatment, including regimens for patients both eligible and ineligible for autologous stem-cell transplant (ASCT).
The latest approval follows October 2024's indication extension for daratumumab-VRd to treat newly diagnosed patients eligible for ASCT, supported by the Phase III PERSEUS trial results.
The trial focused on assessing the therapy's SC-based quadruplet regimen for consolidation and induction therapy with daratumumab SC and lenalidomide maintenance.
The trial assessed the safety and efficacy of daratumumab-VRd against VRd in NDMM subjects who were either transplant ineligible or for whom ASCT was not intended as initial treatment.
Daratumumab-VRd's overall safety profile was consistent with the known profiles of daratumumab SC and VRd.
Johnson & Johnson innovative medicine EMEA therapeutic area haematology lead Edmond Chan stated: 'Daratumumab has become a cornerstone of multiple myeloma treatment over the past decade and is now the only anti-cluster of differentiation 38 (CD38) antibody approved to treat all patient types in the frontline setting, regardless of transplant eligibility.
'This latest approval confirms the enhanced benefit of daratumumab SC-based quadruplet regimens and its versatility and effectiveness in addressing the diverse needs of those affected by this complex disease.'
J&J also filed a supplemental biologics licence application with the US Food and Drug Administration in September 2024 for a new indication for daratumumab SC with VRd to treat adults with NDMM who are either ineligible for ASCT or for whom ASCT is deferred.
In 2024, the company announced the submission of a type II variation application to the European Medicines Agency (EMA) for its Darzalex-based quadruplet therapy for MM.
In 2012, J&J's Janssen Biotech and Genmab entered a global agreement granting J&J exclusive development, manufacturing and commercialisation rights for daratumumab.
"EC approves extension of indication for Janssen-Cilag's Darzalex" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
J&J Snack Foods (JJSF) Reports Earnings Tomorrow: What To Expect
Snack food company J&J Snack Foods (NASDAQ:JJSF) will be reporting earnings this Tuesday morning. Here's what investors should know. J&J Snack Foods missed analysts' revenue expectations by 3.2% last quarter, reporting revenues of $356.1 million, down 1% year on year. It was a disappointing quarter for the company, with a significant miss of analysts' adjusted operating income estimates and a significant miss of analysts' EBITDA estimates. Is J&J Snack Foods a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting J&J Snack Foods's revenue to grow 1.2% year on year to $445.3 million, slowing from the 3.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.76 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. J&J Snack Foods has missed Wall Street's revenue estimates five times over the last two years. Looking at J&J Snack Foods's peers in the shelf-stable food segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Hershey delivered year-on-year revenue growth of 26%, beating analysts' expectations by 3.1%, and Lamb Weston reported revenues up 4%, topping estimates by 5.7%. Hershey's stock price was unchanged after the resultswhile Lamb Weston was up 19.3%. Read our full analysis of Hershey's results here and Lamb Weston's results here. Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the shelf-stable food stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.4% on average over the last month. J&J Snack Foods is down 3.6% during the same time and is heading into earnings with an average analyst price target of $144 (compared to the current share price of $112.21). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. 登入存取你的投資組合
Yahoo
2 days ago
- Yahoo
Singer Jessie J returned to hospital with ‘infection' and ‘fluid on my lungs'
Singer Jessie J has revealed she returned to hospital where an 'infection' and 'a little fluid' on her lungs were discovered. The 37-year-old, whose real name is Jessica Cornish, said she has since discharged herself from the hospital where she was treated after breast cancer surgery just weeks ago, revealing in July that she had since seen 'no cancer spread'. In a post on Instagram, the Price Tag singer said: 'Six weeks post surgery and I was back in the same ward I was after my surgery. Not expected or planned. 'I had and still have symptoms that pointed towards a blood clot on the lung, it is not a blood clot thank god. 'They ran a lot of tests, which ended up showing I have an infection (still trying to figure out what) and a little fluid on my lungs. 'Finding it hard to breathe in, but I discharged myself last night (I hate being in hospital) and will continue the investigation as an outpatient.' She went on to say it was 'frustrating' that her career plans had to change due to her surgery and hospital visits, and added that she had been 'working so hard to get to this point and excited to do it all'. Cornish said: 'I know for me, the true hard journey of this whole thing physically was the day I went into surgery. 'The recovery physically is far from quick or easy, and mentally it's been the most challenging time for me, especially as a mum with a toddler and being unable to be the mother I usually am.' The star said her visit to hospital was a 'reminder to myself to slow down' even though she felt she was already at a slow pace. Cornish added: 'This isn't a speedy recovery and it isn't meant to be. 'As an ADHD Aries, fire breathing dragon t-rex, I can do it myself, I'm always ok woman. That slow pace has been a hard reality to accept to be honest. 'I love moving and working and being up and active but I can't be right now, and that's what it is, and I am finding the strength knowing that all can be adjusted to align with a slower pace and the support of my very small inner support circle.' The London-born singer welcomed her son, Sky Safir Cornish Colman, in 2023, having had a miscarriage in November 2021. She has battled with ill-health throughout her life, having been diagnosed with a heart condition aged eight, suffering a minor stroke aged 18 and having briefly gone deaf in 2020. The singer-songwriter has had three number one songs in the UK singles chart with Domino, Price Tag and Bang Bang. She was awarded four Mobo awards in 2011 including best UK act, best newcomer, best song for Do It Like A Dude and best album with Who You Are, and won the Brit Award for rising star in 2011.
Yahoo
3 days ago
- Yahoo
According To Longevity Experts, This Is The Breakfast You Should Be Eating For A Long Life
According to scientific research, if you make healthy eating a regular, normal thing, it can increase how long you live up to a full decade — that's major. Considering that humans are creatures who favor routine, there's a good chance that what you eat and drink is the same every morning. Maybe your coffee pot is set to start brewing while you're still snoozing and you pour yourself a bowl of cereal while you're still rubbing sleep out of your eyes. If you're going to have the same meal on repeat every morning, it's worth it to make sure it's one that adds years to your life, playing into the aforementioned stat. We asked top longevity experts what they eat for breakfast for inspiration, which they share here along with tips for ensuring your breakfast adds years to your life. What Longevity Experts Eat For Breakfast Related: Dr. Suzanne J. Ferree, who is double-board certified in family medicine and anti-aging and regenerative medicine, and Raghav Sehgal, a Ph.D. student and Gruber Fellow at Yale University whose research focuses on human aging, both told HuffPost that they start their day with veggies and eggs. 'I eat baked, pasture-raised egg bites with mixed organic, colorful vegetables cooked with organic pure olive or avocado oil,' Ferree shared. Sehgal's breakfast is similar: a veggie omelet made with spinach, tomatoes, mushrooms and, sometimes, a little cheese. 'I usually pair it with a side of avocado or some smoked salmon if I'm feeling fancy,' he added. Both of the experts say an egg/veggie breakfast is loaded with nutrients scientifically connected to longevity. 'This kind of breakfast is great because it's loaded with protein, which is great for your musculoskeletal health. The veggies add a bunch of vitamins and antioxidants, as well as fiber, which are great for gut health. Additionally, the healthy fats from the avocado or salmon are awesome for your cardiac and cognitive health,' Sehgal said. One scientific study that took into account more than 18,000 adults found that eating eggs regularly was not only linked to a lower mortality rate, but that it significantly lowered total mortality. As for veggies, you probably won't be surprised to hear that a veggie-forward diet is linked to lowering the risk for many chronic diseases that can threaten lifespan. Dr. Monisha Bhanote, a quintuple board-certified physician and longevity expert, also incorporates veggies into her breakfast, but she does it in a different way than Sehgal and Ferree. 'Two breakfasts I enjoy regularly are coconut yogurt topped with hemp seeds and blueberries, which is quick and easy, and baked purple sweet potato with cashew miso dressing, which is both satisfying and deeply nourishing,' she told HuffPost. Purple sweet potatoes are a staple in Okinawa, a 'Blue Zone' where it's common to live into the triple digits and still be in good health. This specific type of tuber is high in anthocyanins, a type of flavonoids (antioxidants) that help protect against chronic inflammation. The cashew miso dressing Bhanote drizzles on top provides protein and unsaturated fats. When Bhanote opts for coconut yogurt for breakfast, she gets her protein from the yogurt and hemp seeds. 'Hemp seeds are an excellent source of omega-3 and omega-6 fatty acids in an optimal ratio, supporting heart health and reducing inflammation,' Bhanote said. She also pointed out that the probiotics in coconut yogurt promote a healthy gut microbiome, which helps reduce inflammation and supports a strong immune system, which are both essential for longevity. The blueberries are high in fiber and antioxidants, which help protect against chronic inflammation. Tips For Ensuring Your Own Breakfast Adds Years To Your Life In general, all three experts say that avoiding ultra-processed foods and fatty meats (like sausage or bacon) at breakfast is one big way to ensure your morning meal is adding years to your life instead of subtracting them. Scientific research shows that a diet high in ultra-processed foods is directly linked to reducing lifespan. Similarly, eating red or processed meat regularly increases the risk for cardiovascular disease and certain types of cancer. All three experts say minimizing added sugar at breakfast is another way to add years to your life. That means avoiding sugary cereals, flavored yogurts and pastries. 'For a longevity-supporting breakfast, focus on whole, nutrient-dense foods that provide a balance of healthy fats, proteins and complex carbohydrates. Incorporate plenty of antioxidants from fruits like berries, healthy fats from nuts, seeds, or avocados and fiber-rich vegetables or whole grains,' Sehgal advised. He also said that including probiotic-rich foods like yogurt or miso, as Bhanote's breakfast does, can support gut health, which plays a critical role in overall well-being and longevity. It comes to no surprise that plants reign supreme when it comes to the breakfasts of choice for longevity experts. Consider this a reminder to get your fill of them in the morning. While vegetables are often regulated to lunch and dinner, incorporating them into your breakfast along with an unprocessed protein source is a science-backed way to increase your lifespan. Starting your morning by adding years to your life? Not too shabby of a way to start the day. Use it to set the tone and keep the longevity-supporting habits coming. With hope, you'll be doing them for many, many years to article originally appeared on HuffPost.
